News & Press Releases
Filter by:
Mintz Advises Philips on SpectraWAVE Acquisition
December 18, 2025
Mintz is pleased to have represented Royal Philips, a global leader in health technology, in entering into an agreement to acquire SpectraWAVE, Inc., an innovator in Enhanced Vascular Imaging of coronary arteries, angiography-based physiology assessments, and the use of AI in medical imaging. SpectraWAVE’s intravascular imaging and physiological assessment technologies provide advanced solutions for the treatment of patients with coronary artery disease, affecting more than 300 million people worldwide.
Mintz Advises TPG on Sale of Equity Interest in OneOncology to Cencora
December 17, 2025
Mintz advised TPG on Cencora’s acquisition of TPG’s equity interest in OneOncology, a physician-led national platform empowering independent medical specialty practices rooted in oncology. The transaction follows a period of significant physician-led investment and growth for the platform.
Mintz Elevates Twelve New Partners
December 17, 2025
Mintz announces the elevation of 12 attorneys to its partnership ranks across the US and Canada, effective January 1, 2026. These promotions build on the firm’s growth in 2025, which included 14 lateral partners spanning the firm’s geographies.
Mintz Advises on Protara Therapeutics' $75 Million Public Offering
December 16, 2025
Mintz Advises on Fulcrum Therapeutics' $175 Million Public Offering
December 16, 2025
Mintz advised the underwriters in connection with Fulcrum Therapeutics' $175 million public offering.
Mintz Advises on Wave Life Sciences $402.5 Million Public Offering
December 12, 2025
Mintz advised Wave Life Sciences in its $402.5 million public offering.
